Finfer Simon, Bellomo Rinaldo, Lipman Jeffrey, French Craig, Dobb Geoffrey, Myburgh John
Anzics Clinical Trials Group, 10 Iavers Terrace, Carlton, Victoria 3053, Australia.
Intensive Care Med. 2004 Apr;30(4):589-96. doi: 10.1007/s00134-004-2157-0. Epub 2004 Feb 12.
To determine the population incidence and outcome of severe sepsis occurring in adult patients treated in Australian and New Zealand intensive care units (ICUs), and compare with recent retrospective estimates from the USA and UK.
Inception cohort study.
Twenty-three closed multi-disciplinary ICUs of 21 hospitals (16 tertiary and 5 university affiliated) in Australia and New Zealand.
A total of 5878 consecutive ICU admission episodes.
Main outcome measures were population-based incidence of severe sepsis, mortality at ICU discharge, mortality at 28 days after onset of severe sepsis, and mortality at hospital discharge. A total of 691 patients, 11.8 (95% confidence intervals 10.9-12.6) per 100 ICU admissions, were diagnosed with 752 episodes of severe sepsis. Site of infection was pulmonary in 50.3% of episodes and abdominal in 19.3% of episodes. The calculated incidence of severe sepsis in adults treated in Australian and New Zealand ICUs is 0.77 (0.76-0.79) per 1000 of population. 26.5% of patients with severe sepsis died in ICU, 32.4% died within 28 days of the diagnosis of severe sepsis and 37.5% died in hospital.
In this prospective study, 11.8 patients per 100 ICU admissions were diagnosed with severe sepsis and the calculated annual incidence of severe sepsis in adult patients treated in Australian and New Zealand ICUs is 0.77 per 1000 of population. This figure for the population incidence falls in the lower range of recent estimates from retrospective studies in the U.S. and the U.K.
确定在澳大利亚和新西兰重症监护病房(ICU)接受治疗的成年患者中发生严重脓毒症的人群发病率及转归,并与美国和英国近期的回顾性估计值进行比较。
队列起始研究。
澳大利亚和新西兰21家医院(16家三级医院和5家大学附属医院)的23个封闭式多学科ICU。
共有5878例连续的ICU入院病例。
主要结局指标为基于人群的严重脓毒症发病率、ICU出院时的死亡率、严重脓毒症发病后28天的死亡率以及医院出院时的死亡率。共有691例患者被诊断为752次严重脓毒症发作,每100例ICU入院患者中有11.8例(95%置信区间10.9 - 12.6)。感染部位在50.3%的发作中为肺部,在19.3%的发作中为腹部。在澳大利亚和新西兰ICU接受治疗的成年患者中,严重脓毒症的计算发病率为每1000人中有0.77例(0.76 - 0.79)。26.5%的严重脓毒症患者在ICU死亡,32.4%在严重脓毒症诊断后28天内死亡,37.5%在医院死亡。
在这项前瞻性研究中,每100例ICU入院患者中有11.8例被诊断为严重脓毒症,在澳大利亚和新西兰ICU接受治疗的成年患者中,严重脓毒症的计算年发病率为每1000人中有0.77例。这一人群发病率数字处于美国和英国近期回顾性研究估计值的较低范围。